The SLC19A3 gene gives cells instructions for moving vitamin B1 into tissues, especially the brain. Your cells depend on this gene when they need to use thiamine to make energy and keep nerve cells working. If it does not work well, a person may develop episodes of confusion, seizures, movement problems, or trouble walking. Severe variants in both copies of the gene can cause a treatable brain condition, often in childhood. Early treatment with thiamine, often along with biotin, can help limit symptoms.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or direct processes in the body. Some genes hold the code for making proteins, the parts of cells that do much of the work. Others mainly regulate when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in LearnHub.
Overview
SLC19A3Gene function
What if the gene works
The SLC19A3 gene helps move vitamin B1 into cells. This supports energy production, especially in the brain, and helps nerve cells work properly.
Risk
What if the gene does not work
Variants in the SLC19A3 gene can disrupt thiamine transport and cause a brain condition with episodes of confusion, seizures, movement problems, or weakness. Effects range from milder, later-onset forms to severe early childhood disease, and some people develop hearing loss.
Treatment
What does that mean for your treatment
Pathogenic variants in the SLC19A3 gene guide treatment toward thiamine, usually with biotin, because this is the established disease specific therapy. Many clinicians continue both long term, and treatment during illness or relapse may need closer supervision. Response varies, but starting thiamine early can greatly improve symptoms and reduce further episodes.
Conditions associated with SLC19A3
Gene function
What if the gene works
Your cells need vitamin B1 to turn food into usable energy. The SLC19A3 gene helps move this vitamin into the body and into cells, where it can be put to work. This supports steady, day to day cell activity.
The SLC19A3 gene helps make a transporter that carries vitamin B1 through cell membranes and into cells. This gives cells access to a nutrient they need for routine work.
In the intestines, this transporter helps absorb vitamin B1 from food. In the kidneys, it helps the body keep some vitamin B1 rather than losing too much in urine.
Once inside cells, vitamin B1 supports helper proteins that release energy from food and keep basic cell chemistry moving. This is part of how the SLC19A3 gene helps the body use vitamin B1.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, such as variation in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change a gene’s function more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the SLC19A3 gene change the shape, stability, or cell delivery of its transporter, so cells take up less vitamin B1 (thiamine). How SLC19A3 variants affect thiamine transport varies: some changes leave partial activity, while more disruptive variants can greatly reduce or stop transport. This loss of function can limit energy production in brain cells. In people with SLC19A3-related disease, stronger loss of function often links to earlier onset or a more severe course.
How variants are linked to conditions
Among the conditions linked to the SLC19A3 gene, the best established is biotin-thiamine-responsive basal ganglia disease, also called thiamine metabolism dysfunction syndrome 2. Pathogenic variants can cause episodes of encephalopathy, seizures, movement changes, and trouble walking or speaking. This is a rare inherited condition, and symptoms can begin in infancy, childhood, or later.
A variant is not necessarily a diagnosis
Variants in genes are a usual feature of human biology and occur widely across the population. Most do not directly affect health and instead represent normal human variation. With many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences contribute. In other situations, though, one well understood variant in a particular gene is enough to establish a diagnosis.
Are there things that can increase or change my risk?
For SLC19A3, the chance of developing the related condition is mainly set by whether someone is born with harmful changes in both copies of the gene. In people living with these changes, infections, fever, and other body stress can trigger sudden worsening, so early diagnosis, quick treatment, and close follow-up matter most.
Inheritance of SLC19A3 variants
SLC19A3-related conditions are inherited in an autosomal recessive pattern. This means a child usually inherits one SLC19A3 variant from each parent, and the parents are often healthy carriers. When both parents carry a variant in the SLC19A3 gene, each pregnancy has a 25% chance of resulting in an affected child, a 50% chance of a child who is also a carrier, and a 25% chance of a child with no familial variant. In families learning how SLC19A3 variants are inherited, it helps to know that this pattern affects sons and daughters equally.
What does my SLC19A3 result mean for my family?
For families affected by a harmful change in the SLC19A3 gene, the pattern is usually recessive, which means brothers and sisters may also be affected or may carry the same gene change without symptoms. Parents are often healthy carriers, and other close relatives may be carriers too. Because of this, family members may wish to talk with their care team about whether genetic testing could help clarify their own results.
Genetic information
Genetic testing
How you find out about variants
Variants in the SLC19A3 gene are usually found with a blood sample or cheek swab sent for genetic testing for SLC19A3 variants. A lab reads the gene's DNA code to look for changes and compares them with known findings. Results may show two variants, one variant, or no relevant variant.
When should I consider getting a genetic test?
Consider SLC19A3 testing if a child or adult has unexplained episodes of confusion, seizures, trouble walking, or sudden movement changes, especially after a fever or infection, or if this condition runs in the family. Finding a harmful change in SLC19A3 can confirm an inherited condition and help guide treatment.
A genetic result is only one part of your health story
How much a genetic result can tell you depends on the condition and the kind of variant involved, though it can provide meaningful insight. Over time, many factors influence how the body works, including lifestyle, environment, age, and medical history. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when considered with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that works well for one person may work less well for another, or cause more side effects, because the body can absorb, move, break down, or respond to a drug differently. These differences are common and are one reason medication response is not the same for everyone. Genetic results are just one part of the picture, alongside age, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics studies how genetic differences can shape a person’s response to medication. It examines relationships between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes can affect both how strongly a drug works and how the body handles it. This information can support more informed, individualized treatment decisions. If you want to learn more about this topic, you can read more in the LearnHub.
Drugs influenced by the SLC19A3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dosing, so questions about medicines, side effects, or treatment changes are best discussed with your doctor.
History
The SLC19A3 gene entered medical genetics through studies of children with episodes of confusion, movement changes, and brain swelling affecting the deep brain regions called the basal ganglia. In recent decades, awareness of this gene’s role has grown. In the early 2000s, researchers linked pathogenic variants in the SLC19A3 gene to what became known as biotin thiamine responsive basal ganglia disease, a finding that was especially important because symptoms could improve when recognized early. Scientific classifications changed as researchers learned more about the gene. Over time, related syndromes that had seemed separate were understood to belong to the same genetic condition. This history made the SLC19A3 gene notable as one of the clearer examples in neurology where a genetic diagnosis can directly shape treatment.